ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Patheon To Acquire Solubility Specialist

by Michael McCoy
March 16, 2015 | APPEARED IN VOLUME 93, ISSUE 11

In its second deal in as many weeks, Patheon has agreed to buy Agere Pharmaceuticals, which specializes in improving the absorption rate, or bioavailability, of drugs. Patheon says Agere’s Bend, Ore., headquarters will become a solubility center of excellence for its pharmaceutical development services operations. Patheon, which last year merged with DSM’s fine chemicals business, is in the process of acquiring the pharmaceutical chemical firm Irix Pharmaceuticals.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment